September 27, 2011
Otsuka Pharmaceutical announced on September 26 that it received on the same day marketing approval for its dry eye treatment Mucosta UD 2% ophthalmic suspension (rebamipide). In a domestic PIII clinical trial, the efficacy and safety of the drug was...read more